COVID vaccine effective for 90% of cancer patients, Israeli study finds | The Times of Israel
Matthew L. Meyerson, MD, PhD - DF/HCC
Joelle Hallak - Associate Director, HEOR Real World Evidence (RWE) Analytics - AbbVie | LinkedIn
Past Seminars - Health Care Management
Joelle Hallak - Associate Director, HEOR Real World Evidence (RWE) Analytics - AbbVie | LinkedIn
Pharmaceuticals | Free Full-Text | Tumor-Targeted Fluorescent Proteinoid Nanocapsules Encapsulating Synergistic Drugs for Personalized Cancer Therapy
Posttraumatic Growth in Breast Cancer Survivors: Constructive and Illusory Aspects - Pat‐Horenczyk - 2015 - Journal of Traumatic Stress - Wiley Online Library
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib - Annals of Oncology
Prof. Ruth Shalgi-Harsina | Sackler Faculty of Medicine
Patients with cancer achieve response to messenger RNA COVID-19 vaccine
Prof. Naphtali Savion | Sackler Faculty of Medicine
Posttraumatic Growth in Breast Cancer Survivors: Constructive and Illusory Aspects - Pat‐Horenczyk - 2015 - Journal of Traumatic Stress - Wiley Online Library
More Data on COVID-19 Vaccination and Cancer | Cancer Today
Study: COVID-19 shots shown effective in cancer patients up to 4 months later - UPI.com
COVID Booster May Benefit Active-Treatment Cancer Patients
Kimberly Lynn Blackwell, MD | medicine.duke.edu
Transnational cancer research lab | Felsenstein Medical Research Center
COVID-fighting antibodies last 4+ months in 87% of cancer patients: Israeli MDs | The Times of Israel
EX-99.1 2 f6k060319ex99-1_canfitebio.htm PRESS RELEASE DATED JUNE 3, 2019 Exhibit
Findings from Can-Fite's Phase II Liver Cancer Study were Presented at ASCO Annual Meeting Late-Breaking Session | Business Wire
MD Anderson study finds ribociclib improves survival for women with metastatic breast cancer | MD Anderson Cancer Center
Findings from Can-Fite's Phase II Liver Cancer Study were Presented at ASCO Annual Meeting Late-Breaking Session | Business Wire
Exclusive program launched for medical industry leaders - Globes
Joelle Hallak - Associate Director, HEOR Real World Evidence (RWE) Analytics - AbbVie | LinkedIn
Pharmaceuticals | Free Full-Text | Tumor-Targeted Fluorescent Proteinoid Nanocapsules Encapsulating Synergistic Drugs for Personalized Cancer Therapy
References in Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial - The Lancet
First-of-its-kind study in Israel finds that cancer patients are safe for COVID-19 vaccines - EJP
Oncotype DX test predicts chemotherapy benefit
